The Trump administration is preparing to implement a controversial shift in its Ebola response strategy that will see U.S. citizens exposed to the virus treated in Kenya rather than being repatriated to specialised medical facilities in the United States.
According to officials familiar with the plan, the move marks a departure from previous outbreak protocols in which exposed Americans—including health workers and government personnel—were routinely flown back to the U.S. for monitoring and treatment in high-security isolation units.
Under the new arrangement, Americans who are potentially exposed to Ebola will be transported to a designated medical facility in Kenya, where they will undergo quarantine, observation, and treatment if symptoms develop. Cases requiring advanced intervention may still be evaluated for possible transfer to Europe.
The policy shift comes against the backdrop of a rapidly escalating Ebola outbreak in the Democratic Republic of Congo, which health authorities estimate has surpassed 1,000 infections and more than 200 deaths within a short period since its detection, prompting fears of wider regional spread.
As part of the operational framework, the U.S. government is training Public Health Service officers for deployment to Kenya to provide frontline medical support to exposed citizens. The teams are expected to work in coordination with the State Department, the Department of Defense, and the Department of Health and Human Services.
The administration is also establishing a dedicated treatment and quarantine facility in Kenya, which will serve as the central hub for monitoring exposed Americans and managing confirmed or suspected cases.
Officials argue the approach is designed to contain potential cross-border spread while maintaining continuity of care closer to the outbreak’s epicentre. However, the decision departs sharply from long-standing U.S. public health practice, which prioritises repatriation to domestic facilities equipped with specialised Ebola treatment units.
The United States maintains some of the most advanced high-level isolation centres in the world, including units capable of handling highly infectious diseases such as Ebola. Previous administrations have consistently relied on these facilities to manage exposure cases involving American citizens.
Public health experts have raised concerns about the feasibility of replicating such capacity in a newly established overseas facility within a short timeframe, warning that treatment outcomes are often tied to the sophistication of specialised infrastructure and clinical experience.
The Ebola outbreak in eastern and central Africa continues to pose significant containment challenges due to population movement and ongoing insecurity in affected regions, particularly in parts of eastern Congo where access to health services remains limited.
The White House has not publicly commented on the reported policy decision.




